SCHEMBL26324941

SCHEMBL26324941

CC(C)OC(=O)C(C(C)C)N(Cc1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
MMP2 P08253 5/20 0.44
MMP9 P14780 5/20 0.44
MMP8 P22894 4/20 0.44
MMP13 P45452 3/20 0.44
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
HPGD P15428 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26324920 0.86 TSHR (0.44) TSHRMMP2MMP9MMP8MMP13
SCHEMBL25440133 0.85 TSHR (0.49) TSHRALDH1A1LMNAPOLBHSD17B10
SCHEMBL26325026 0.84 TSHR (0.50) TSHRMMP2MMP9MMP8MMP13
SCHEMBL26324890 0.81 ALDH1A1 (0.39) TSHRALDH1A1LMNAPOLBHSD17B10
SCHEMBL26324865 0.81 TSHR (0.38) TSHRMMP2MMP9MMP8MMP13
SCHEMBL26324800 0.79 TSHR (0.42) TSHRMMP2MMP9MMP8MMP13
SCHEMBL26324873 0.77 TSHR (0.41) TSHRMMP2MMP9MMP8MMP13
SCHEMBL9652428 0.75 TSPO (0.44) TSHRALDH1A1MEN1KMT2ACHRNB2
SCHEMBL25440223 0.74 TSHR (0.46) TSHRHDAC1HDAC6MEN1KMT2A
SCHEMBL26324913 0.74 SIGMAR1 (0.49) TSHRHDAC1HDAC6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 TSHR 2716/4885MMP2 4568/4885MMP9 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.